CPS
  • Home

Sign in or register to track your progress, save, and view your completed history.

Breast Cancer​

Scoring of PD-L1 in a Triple-Negative Breast Cancer (TNBC) Case

    clockimg 15m
  • Case Walkthrough
  • Foundational
 saveimgSave unsaveimgUnsave

Join special guest, Dr. David Hardisson, as he reviews the basics of Combined Positive Score (CPS), and walks through several cases of Triple Negative Breast Cancer (TNBC) stained with PD-L1 IHC 22C3 pharmDx. This video is great for those just starting out with PD-L1 evaluation using CPS.​

 

 

The Spotlight Video Series walks you through CPS principles and scoring strategies for cases stained with PD-L1 IHC 22C3 pharmDx. Through this engaging series, Agilent PD-L1 experts will help you to confidently:​

  • Evaluate H&E, NCR, and PD-L1 slides for adequacy ​
  • Understand inclusion/exclusion criteria and other core principles of Combined Positive Score (CPS)​
  • Determine the best approaches for scoring cases based on specific characteristics and features​
  • Navigate challenging morphology and staining characteristics​
David Hardisson, MD​

David Hardisson, MD​

Professor of Pathology​, University Hospital of La Paz, Madrid​

Related Training

This website discusses general principles for CDx scoring and is intended for educational purposes only. Not all cancer indications mentioned are approved worldwide. Please consult local Instructions for Use for more information.D0113770_1.00